Literature DB >> 33461623

Spreading of TDP-43 pathology via pyramidal tract induces ALS-like phenotypes in TDP-43 transgenic mice.

Xuebing Ding1,2, Zhi Xiang1,2, Chi Qin1,2, Yongkang Chen1,2, Haiyan Tian1,2, Lin Meng1,2, Danhao Xia1,2, Han Liu1,2, Jia Song3, Jun Fu3, Mingming Ma4, Xuejing Wang5,6.   

Abstract

Transactive response DNA-binding protein 43 kDa (TDP-43) has been identified as the major component of ubiquitinated inclusions found in patients with sporadic amyotrophic lateral sclerosis (ALS). Increasing evidence suggests prion-like transmission of TDP-43 aggregates via neuroanatomic connection in vitro and pyramidal tract in vivo. However, it is still unknown whether the spreading of pathological TDP-43 sequentially via pyramidal tract can initiate ALS-like pathology and phenotypes. In this study, we reported that injection of TDP-43 preformed fibrils (PFFs) into the primary motor cortex (M1) of Thy1-e (IRES-TARDBP) 1 mice induced the spreading of pathological TDP-43 along pyramidal tract axons anterogradely. Moreover, TDP-43 PFFs-injected Thy1-e (IRES-TARDBP) 1 mice displayed ALS-like neuropathological features and symptoms, including motor dysfunctions and electrophysiological abnormalities. These findings provide direct evidence that transmission of pathological TDP-43 along pyramidal tract induces ALS-like phenotypes, which further suggest the potential mechanism for TDP-43 proteinopathy.

Entities:  

Keywords:  Amyotrophic lateral sclerosis; Preformed fibrils; Prion-like transmission; Pyramidal tract; Transactive response DNA-binding protein 43 kDa

Year:  2021        PMID: 33461623     DOI: 10.1186/s40478-020-01112-3

Source DB:  PubMed          Journal:  Acta Neuropathol Commun        ISSN: 2051-5960            Impact factor:   7.801


  40 in total

Review 1.  Prion-like mechanisms in amyotrophic lateral sclerosis.

Authors:  Jacob I Ayers; Neil R Cashman
Journal:  Handb Clin Neurol       Date:  2018

Review 2.  The transcellular spread of cytosolic amyloids, prions, and prionoids.

Authors:  Adriano Aguzzi; Lawrence Rajendran
Journal:  Neuron       Date:  2009-12-24       Impact factor: 17.173

Review 3.  Phosphorylated and cleaved TDP-43 in ALS, FTLD and other neurodegenerative disorders and in cellular models of TDP-43 proteinopathy.

Authors:  Tetsuaki Arai; Masato Hasegawa; Takashi Nonoka; Fuyuki Kametani; Makiko Yamashita; Masato Hosokawa; Kazuhiro Niizato; Kuniaki Tsuchiya; Zen Kobayashi; Kenji Ikeda; Mari Yoshida; Mitsumoto Onaya; Hiroshige Fujishiro; Haruhiko Akiyama
Journal:  Neuropathology       Date:  2010-01-19       Impact factor: 1.906

4.  Stages of pTDP-43 pathology in amyotrophic lateral sclerosis.

Authors:  Johannes Brettschneider; Kelly Del Tredici; Jon B Toledo; John L Robinson; David J Irwin; Murray Grossman; EunRan Suh; Vivianna M Van Deerlin; Elisabeth M Wood; Young Baek; Linda Kwong; Edward B Lee; Lauren Elman; Leo McCluskey; Lubin Fang; Simone Feldengut; Albert C Ludolph; Virginia M-Y Lee; Heiko Braak; John Q Trojanowski
Journal:  Ann Neurol       Date:  2013-06-19       Impact factor: 10.422

Review 5.  Amyotrophic Lateral Sclerosis.

Authors:  Robert H Brown; Ammar Al-Chalabi
Journal:  N Engl J Med       Date:  2017-07-13       Impact factor: 91.245

6.  TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis.

Authors:  Tetsuaki Arai; Masato Hasegawa; Haruhiko Akiyama; Kenji Ikeda; Takashi Nonaka; Hiroshi Mori; David Mann; Kuniaki Tsuchiya; Mari Yoshida; Yoshio Hashizume; Tatsuro Oda
Journal:  Biochem Biophys Res Commun       Date:  2006-10-30       Impact factor: 3.575

Review 7.  Amyotrophic lateral sclerosis--a model of corticofugal axonal spread.

Authors:  Heiko Braak; Johannes Brettschneider; Albert C Ludolph; Virginia M Lee; John Q Trojanowski; Kelly Del Tredici
Journal:  Nat Rev Neurol       Date:  2013-11-12       Impact factor: 42.937

Review 8.  The cell biology of prion-like spread of protein aggregates: mechanisms and implication in neurodegeneration.

Authors:  Maddalena Costanzo; Chiara Zurzolo
Journal:  Biochem J       Date:  2013-05-15       Impact factor: 3.857

9.  TDP-43 pathology and neuronal loss in amyotrophic lateral sclerosis spinal cord.

Authors:  Johannes Brettschneider; Kimihito Arai; Kelly Del Tredici; Jon B Toledo; John L Robinson; Edward B Lee; Satoshi Kuwabara; Kazumoto Shibuya; David J Irwin; Lubin Fang; Vivianna M Van Deerlin; Lauren Elman; Leo McCluskey; Albert C Ludolph; Virginia M-Y Lee; Heiko Braak; John Q Trojanowski
Journal:  Acta Neuropathol       Date:  2014-06-12       Impact factor: 17.088

10.  Characterization and functional implications of the RNA binding properties of nuclear factor TDP-43, a novel splicing regulator of CFTR exon 9.

Authors:  E Buratti; F E Baralle
Journal:  J Biol Chem       Date:  2001-07-24       Impact factor: 5.157

View more
  3 in total

Review 1.  Mechanisms of TDP-43 Proteinopathy Onset and Propagation.

Authors:  Han-Jou Chen; Jacqueline C Mitchell
Journal:  Int J Mol Sci       Date:  2021-06-02       Impact factor: 5.923

Review 2.  Prionoids in amyotrophic lateral sclerosis.

Authors:  Philippe Gosset; William Camu; Cedric Raoul; Alexandre Mezghrani
Journal:  Brain Commun       Date:  2022-06-09

Review 3.  The Interplay Between Autophagy and RNA Homeostasis: Implications for Amyotrophic Lateral Sclerosis and Frontotemporal Dementia.

Authors:  O H Houghton; S Mizielinska; P Gomez-Suaga
Journal:  Front Cell Dev Biol       Date:  2022-04-28
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.